首页 沃尔格林-联合博姿(usWBA)-基本信息

沃尔格林-联合博姿(usWBA)-基本信息

日报更新时间:04-10 10:00

周报更新时间:04-11 03:39

行情信息

今开价:54.33

最高价:55.05

成交量:3822320.0

昨收价:54.18

最低价:54.12

最新价:54.7

行情图标
概要信息

中文名称:沃尔格林-联合博姿


英文名称:Walgreens Boots Alliance


简介:沃尔格林长靴联盟公司于1909年作为Illinois corporation成立


电话:1-847-3152500


最新量化综合结论
百科信息
  • 相关网站
  • 百科
  • 员工交易记录
  • 持股信息
  • 领导人信息

沃尔格林联合博姿(Walgreens Boots Alliance)是美国最大的连锁药店,公司分为3个部门来运作:Retail Pharmacy USA(美国零售药房), Retail Pharmacy International(全球零售药房), 和 Pharmaceutical Wholesale(药品批发)。1、美国零售药房:通过其零售药店和便利的护理诊所销售处方药和各种一般商品,包括非处方药,美容产品,照片整理,季节性商品,贺卡和方便食品。 该部门还提供专业药房服务和邮购服务; 并管理店内诊所。截至2017年8月31日,该部门在美国的Walgreens和Duane Reade品牌下运营了8,100家零售店; 和7家专科药房,以及约400个店内诊所。2、全球零售药房:销售处方药; 以及通过药房主导的健康和美容店和眼镜店(近视镜),以及boots.com和集成的APP销售健康,美容,化妆品和其他消费产品。截至2017年8月31日,该部门在英国,泰国,挪威,爱尔兰共和国,荷兰,墨西哥和智利以Boots,Benavides和Ahumada批评经营了4,722家零售药商;和637家眼镜店(optical practices),其中包括178家加盟店。3、药品批发:从事批发和分销专业和仿制药,保健和美容产品,家庭保健用品和设备,并向药店和其他医疗保健提供者提供相关服务。该部门在法国,英国,德国,土耳其,西班牙,荷兰,埃及,挪威,罗马尼亚,捷克共和国和立陶宛运营。沃尔格林联合博姿Walgreens Boots Alliance(WBA)历史百科:沃尔格林公司:沃尔格林在美国各地的药店中提供消费者商品的销售和多项服务,公司设有沃尔格林健康服务分部、沃尔格林健康与全适能分部,沃尔格林也经营数间网络商店,包括大家耳熟能详的:Beauty.com、Drugstore.com和VisionDirect.com。 沃尔格林在1901年成立。 1913年,沃尔格林在芝加哥有四间分店。 1919年,沃尔格林已有20间连锁店。 1922年,沃尔格林推出了奶昔饮品,并设立了冰淇淋制造工厂。 1923年,沃尔格林开始在住宅区以外的地方开设分店。 1925年,沃尔格林已有44间分店,年营业额达到120万美元。 1930年,沃尔格林已有397间分店,年营业总额为400万美元。 1934年,沃尔格林在全美31州共有601间分店。 1939年,创始人查尔斯·沃尔格林逝世,他的儿子查尔斯·R·沃尔格林接掌公司。 1986年,沃尔格林自Stop & Shop手中购入了“MediMart”公司。联合博姿集团:联合博姿是一家全球领先的、以药店为主导的国际医药保健美容集团,两大核心业务为以药店为主导的保健美容零售,以及医药的批发与分销。被沃尔格林收购前,联合博姿在全球25个国家有超过11.6万名雇员。 1849年,Boots的创始人John Boot在英国诺丁山开设了第一家Boots店。 1881年,Boot家族的Jesse Boot扩大经营,在诺丁山开设了更多的店面。 1984年,开设了首家在诺丁山外的门店。 1938年,UniChem集团成立,初始业务为向独立药店提供医药产品的批发服务。 1977年,Stefano Pessina 创立了Alleanza Farmaceutica,主营医药批发业务。 1982年,Ornella Barra创立了Di Pharma,主营医药批发业务。 1991年,Alleanza Salute Italia, 与 ERPI 以及 IFP.France合并成立了Alliance Santé公司。 1997年,Alliance Santé与UniChem合并成立了Alliance UniChem集团。 1997年,进入泰国市场。 2006年,Alliance UniChem集团与在诺丁山开设药房起家的Boots集团合并,成立了Alliance Boots 联合博姿集团。 2007年,联合博姿由AB Acquisitions有限公司收购,由上市公司转为一家私有企业。 2012年8月,沃尔格林公司收购联合博姿45%股权,并承诺3年内收购剩余的55%股权。 2012年9月,联合博姿以5600万英镑收购南京医药公司12%股权。 2012年10月,博姿Boots与万宁Mannings结成合作伙伴,在香港的万宁门店开设专柜,出售Boots品牌人气产品,包括No7, Champneys, Extracts andNatural 系列,以及Sabai Arom, Caribbean Cocktail andCollegense等。 2013年3月,联合博姿、沃尔格林一道宣布,与北美最大的医药批发商之一的美源伯根结成长期战略伙伴合作关系。 2013年3月31日,在泰国药店铺总数达200余家,成为泰国最大的健康美容连锁店之一。 2014年8月,联合博姿宣布完成收购阿胡马达药店。该公司旗下的贝纳维德药店是墨西哥第三大零售连锁药店、阿胡马达药店是智利的三大零售连锁药店之一,共计经营约1400家药店。沃尔格林联合博姿Walgreens Boots Alliance(WBA): 2014年12月31日,沃尔格林公司(Walgreen Company,Walgreens)与 联合博姿(Alliance Boots)合并组建——沃尔格林联合博姿集团“Walgreens Boots Alliance”; 2015年11月2日,WBA正式作价94亿美金收购行业老三——来德爱Rite Aid(RAD); 2016年7月28日,Walgreens宣布将关闭Drugstore.com以及Beauty.com,以便专注于自己的Walgreens.com网站; 2016年9月8日,零售药妆店Walgreens Boots计划出售旗下500至1000家门店以获得监管层批准其与Rite Aid的合并案; 2016年12月21日,由于反垄断原因,Fred's将以9.5亿美元的价格收购865家Rite Aid门店; 2017年1月,沃尔格林与Rite Aid达成协议,将收购价格从9.4亿美元降至68-74亿美元; 2017年9月19日,联邦贸易委员会(FTC)批准了第四笔交易协议,以总计43.8亿美元的价格购买1,932家Rite Aid商店; 2017年12月,美国药房连锁企业沃博联(Walgreens Boots Alliance) 称,将收购中国大型医药零售连锁企业国药控股国大药房有限公司(国大药房,原一致药店)40%的股权。沃博联正寻求在中国迅速增长的医疗保健市场进行扩张。

交易日期 交易人 职位 类型 交易份额 价格
2017-08-16 Wilson-Thompson (Kathleen) Officer Gift 1825 --
2017-07-24 Foote (William C) Director Sell 2736 79.79
2017-05-02 Foote (William C) Director Sell 2736 85.89
2017-02-06 Barra (Ornella) Chief Operating Officer Buy 7102 80.48
2017-02-06 Barra (Ornella) Chief Operating Officer Buy 116898 80.96
2017-02-01 Babiak (Janice M) Director Buy 600 80.68
2016-11-27 Wilson-Thompson (Kathleen) Officer Buy 5700 35.50
2016-11-27 Wilson-Thompson (Kathleen) Officer Sell 5700 85.05
2016-11-17 Murphy (Ken) Officer Sell 102172 83.23
2016-11-03 Pessina Stefano Chief Executive Officer Buy 2000000 81.41
2016-11-01 Foote (William C) Director Sell 2067 81.30
2016-10-31 Wilson-Thompson (Kathleen) Officer Sell 3824 82.46
2016-10-31 Schlichting (Nancy M) Director Buy 2304 --
2016-10-20 Wilson-Thompson (Kathleen) Officer Sell 5445 81.57
2016-10-20 Skinner (James A) Officer and Director Buy 77841 --
2016-10-20 Wilson-Thompson (Kathleen) Officer Buy 11914 --
2016-09-07 Wilson-Thompson (Kathleen) Officer Buy 13200 35.50
2016-09-07 Wilson-Thompson (Kathleen) Officer Sell 10796 85.00
2016-09-07 Wilson-Thompson (Kathleen) Officer Buy 10796 35.65
2016-09-07 Wilson-Thompson (Kathleen) Officer Sell 13200 85.00
2016-07-25 Foote (William C) Director Sell 2067 81.35
2016-07-13 Wilson-Thompson (Kathleen) Officer Buy 18899 35.50
2016-07-13 Wilson-Thompson (Kathleen) Officer Sell 10796 83.00
2016-07-13 Wilson-Thompson (Kathleen) Officer Sell 18899 83.00
2016-07-13 Wilson-Thompson (Kathleen) Officer Buy 10796 35.65
2016-07-07 Wilson-Thompson (Kathleen) Officer Buy 18899 35.50
2016-07-07 Wilson-Thompson (Kathleen) Officer Sell 10796 80.86
2016-07-07 Wilson-Thompson (Kathleen) Officer Sell 18899 81.13
2016-07-07 Wilson-Thompson (Kathleen) Officer Buy 10796 35.65
2016-06-09 Wilson-Thompson (Kathleen) Officer Buy 29603 37.30
第 页, 共 3 页 首页 上页 下页 末页

机构持股
持有者 持有份额 持股比例 份额变化 变化率 报告日期
State Street Global Advisors (Aus) Ltd 8684405 0.96% -389280 -4.29% 2019-07-31
Capital Research and Management Company 14514063 1.61% -13561123 -48.30% 2019-07-31
BlackRock Fund Advisors 14936641 1.65% -1114559 -6.94% 2019-07-31
State Street Global Advisors 18655857 2.07% -23120 -0.12% 2019-07-31
Franklin Resources Inc 20494121 2.27% 1581894 8.36% 2019-03-31
Vanguard Investments Australia Ltd 21939347 2.43% -415737 -1.86% 2019-07-31
State Street Corporation 44761457 4.96% 1233185 2.83% 2019-03-31
BlackRock Inc 53707972 5.95% 26075 0.05% 2019-03-31
Vanguard Group Inc 70920571 7.85% -541508 -0.76% 2019-03-31
Norinchukin Zenkyoren Asset Mgmt Co.,Ltd 14475736 1.60% 14461336 100425.94% 2019-07-31
Capital Research & Mgmt Co - Division 3 12351279 1.37% 197932 1.63% 2019-03-31
LSV Asset Management 11672531 1.29% 107600 0.93% 2019-03-31
Templeton Global Advisors Limited 8830052 0.98% 1340028 17.89% 2019-03-31
Invesco Capital Management LLC 9882827 1.09% -1510658 -13.26% 2019-07-31
Caisse De Depot Et Placement Du Quebec 10667865 1.18% 1093610 11.42% 2019-03-31
Fidelity Management & Research Company 10818905 1.20% 3208852 42.17% 2019-07-31
SSGA Funds Management Inc 11294559 1.25% 541503 5.04% 2019-07-31
Geode Capital Management, LLC 11389284 1.26% -11668988 -50.61% 2019-03-31
Northern Trust Corp 11570282 1.28% -70870 -0.61% 2019-03-31
Northern Trust Investments N A 11570282 1.28% -70870 -0.61% 2019-03-31
Amvescap Plc. 11817848 1.31% -355146 -2.92% 2018-12-31
BlackRock Japan Co Ltd 11846019 1.30% -2379 -0.02% 2019-05-31
Nordea Investment Mgmt Bank Demark A/s 22592478 2.47% 3914648 20.96% 2018-12-31
BlackRock Asset Management Canada Ltd 24866165 2.72% 25454 0.10% 2019-05-31
Capital World Investors 15289199 1.67% -2799813 -15.48% 2018-12-31
Bank of New York Mellon Corp 10268410 1.12% -1372445 -11.79% 2018-12-31
JPMorgan Chase & Co 10340832 1.13% -2400149 -18.84% 2018-09-30
Capital Research Global Investors 10910904 1.16% -1469855 -11.87% 2018-09-30
Wellington Management Company LLP 11303119 1.20% -8477224 -42.86% 2018-09-30
BlackRock Institutional Trust Company NA 21093741 2.22% -2357771 -10.05% 2018-06-30
State Street Corp 42674084 4.30% 6499279 17.97% 2018-06-30
Burgundy Asset Management Ltd 7161408 0.72% 986275 15.97% 2018-06-30
Glenview Capital Management LLC 7022969 0.71% -1161958 -14.20% 2018-06-30
Dimensional Fund Advisors, Inc. 6990667 0.70% -4404 -0.06% 2018-06-30
CI Global Holdings Inc 6735501 0.68% -1388878 -17.10% 2018-06-30
Invesco PowerShares Capital Mgmt LLC 10667775 1.07% 1089446 11.37% 2018-06-30
Franklin Mutual Advisers, LLC 6555857 0.66% -9977 -0.15% 2018-06-30
Nordea Inv Management AB, Copenhagen 6325832 0.64% -805395 -11.29% 2018-07-31
Invesco Advisers, Inc 7042274 0.71% 562444 8.68% 2018-03-31
J.P. Morgan Investment Management Inc 9716667 0.98% -883652 -8.34% 2018-03-31
NORGES BANK 8839654 0.89% 83918 0.96% 2017-12-31
Arrowstreet Capital Limited Partnership 5891845 0.59% 5132140 675.54% 2017-12-31
Fidelity Management and Research Company 8986443 0.89% -2552839 -22.12% 2017-09-30
Soroban Capital Partners LP 8024784 0.79% 447700 5.91% 2017-09-30
T. Rowe Price Associates, Inc. 6559534 0.65% -16182573 -71.16% 2017-09-30
Lazard Asset Management LLC 7680077 0.71% 4457421 138.32% 2016-09-30
Kohlberg Kravis Roberts & Co LP 21888376 2.02% -14617447 -40.04% 2016-09-30
共同基金持股
持有者 持有份额 持股比例 份额变化 变化率 报告日期
American Funds AMCAP Fund 2660000 0.29% -474400 -15.14% 2019-06-30
Vanguard Total Stock Market Index Fund 21612704 2.39% -422211 -1.92% 2019-06-30
Vanguard 500 Index Fund 15292314 1.69% -325265 -2.08% 2019-06-30
Nochu JA Asset Plan Fund Growth 14461247 1.60% 14461247 -- 2018-11-16
Invesco QQQ Trust 8211726 0.91% 7252 0.09% 2019-07-31
Vanguard Dividend Appreciation Index Fd 7755873 0.86% 64260 0.84% 2019-06-30
Vanguard Institutional Index Fund 7256488 0.80% -289082 -3.83% 2019-06-30
Fidelity 6293298 0.70% -104812 -1.64% 2019-06-30
Consumer Staples Select Sector SPDR 6117105 0.68% 164304 2.76% 2019-07-31
iShares Core S&P 500 ETF 5695388 0.63% -2808 -0.05% 2019-07-30
Thornburg Investment Income Builder Fund 4950000 0.55% -- -- 2019-06-30
Franklin Mutual Global Discovery Fund 2833972 0.31% -- -- 2019-06-30
DFA US Large Cap Value Portfolio 2936044 0.33% -4063 -0.14% 2019-06-30
American Funds American Mutual Fund 3126700 0.35% -578200 -15.61% 2019-06-30
State Street S&P 500 Index Fund 3437560 0.38% -6300 -0.18% 2019-07-31
Templeton Growth-EUR 3491600 0.39% 623000 21.72% 2019-03-31
SPDR 4383895 0.49% 380185 9.50% 2019-07-31
Vanguard Value Index Fund 4941449 0.55% -226138 -4.38% 2019-06-30
Templeton Growth Fund 3491600 0.39% 623000 21.72% 2019-03-31
American Funds New Perspective Fund 4484500 0.50% 110100 2.52% 2019-03-31
American Funds Invmt Co of Amer 3899600 0.43% -- -- 2019-03-31
iShares Core MSCI AllCntry Wld exCan ETF 5888361 0.64% 1932 0.03% 2019-05-23
iShares MSCI World ETF 5888361 0.64% 1932 0.03% 2019-05-23
iShares Core S&P 500 ETF (CAD-Hedged) 5911062 0.65% 5313 0.09% 2019-05-30
iShares S&P 500 ETF 5911062 0.65% 5313 0.09% 2019-05-30
iShares Core S&P US Total Market ETF 5911062 0.65% 5313 0.09% 2019-05-30
iShares Core MSCI Kokusai ETF 5911062 0.65% 5313 0.09% 2019-05-30
Vanguard Health Care Fund 5732860 0.63% -2315300 -28.77% 2018-12-31
American Funds Washington Mutual Fund 6504900 0.71% -33900 -0.52% 2018-12-31
American Funds Fundamental Invs 3436000 0.38% -- -- 2018-12-31
VA CollegeAmerica Fundamental Inv 3436000 0.36% -- -- 2018-12-31
VA CollegeAmerica WA Mutl Inv Fd 6504900 0.69% -33900 -0.52% 2018-12-31
VA CollegeAmerica New Perspective Fd 4374400 0.46% -- -- 2018-12-31
VA CollegeAmerica The Inv Co of Amer 3899600 0.41% -1307400 -25.11% 2018-12-31
VA CollegeAmerica Amer Mutl Fd 3704900 0.39% 3704900 -- 2018-12-31
VA CollegeAmerica AMCAP Fd 3134400 0.33% -1257700 -28.64% 2018-12-31
OH Putnam Fidelity Spartan 500 Index 6022621 0.64% 174260 2.98% 2019-01-31
Franklin Rising Dividends Fund 2917047 0.31% -196000 -6.30% 2018-11-30
Undrly L&G Diversified Life 3615624 0.38% 3598564 21093.58% 2018-09-30
Undrly L&G Pen PMC Diversified 3615624 0.38% 3598564 21093.58% 2018-09-30
Vanguard Dividend Growth Fund 6250813 0.66% 323500 5.46% 2018-06-30
Vanguard Wellington 6388070 0.67% 243315 3.96% 2018-03-31
Fidelity Spartan 5680886 0.57% 67006 1.19% 2018-07-31
Vanguard Health Care Inv 8048160 0.81% -- -- 2018-06-30
Vanguard Dividend Appreciation ETF 7716533 0.78% 17277 0.22% 2018-07-31
Vanguard Institutional Index I 8248971 0.83% 7507 0.09% 2018-07-31
PowerShares QQQ ETF 8124830 0.84% -31380 -0.38% 2018-09-13
Vanguard 500 Index Inv 15444238 1.56% 18679 0.12% 2018-07-31
Vanguard Total Stock Mkt Idx 21181509 2.13% 89912 0.43% 2018-07-31
VA CollegeAmerica WA Mutual 529B 5798700 0.58% 503200 9.50% 2018-06-30
Vanguard Dividend Growth Inv 6250813 0.63% 323500 5.46% 2018-06-30
Franklin Mutual Global Discovery Z 2833972 0.29% -- -- 2018-07-31
Franklin Rising Dividends Fund A 3113047 0.31% -- -- 2018-07-31
VA CollegeAmerica Amcap 529F 4150000 0.42% -- -- 2018-06-30
VA CollegeAmerica New Perspective 529E 4260900 0.43% 2370900 125.44% 2018-06-30
VA CollegeAmerica Invmt Co of Amer 529E 4820000 0.49% 4820000 -- 2018-06-30
Vanguard Value Index Inv 4681472 0.47% 113176 2.48% 2018-07-31
Thornburg Investment Income Builder A 5049000 0.51% -- -- 2018-07-31
VA CollegeAmerica Fundamental Invs 529E 2986000 0.30% -- -- 2018-06-30
Vanguard Growth Index Inv 2936402 0.30% 11292 0.39% 2018-05-31
DFA US Large Cap Value I 2609521 0.26% 418 0.02% 2018-05-31
Invesco Equity and Income A 2474519 0.25% 244152 10.95% 2018-03-31
Templeton Growth A 2321800 0.23% -- -- 2017-12-31
CREF Stock R1 2540724 0.26% -61765 -2.37% 2018-02-28
Franklin Mutual Shares Z 2283129 0.23% -- -- 2017-12-31
Invesco Diversified Dividend A 3025145 0.30% -- -- 2017-09-30
VA CollegeAmerica Grth Fund of Amer 529F 2950000 0.29% -- -- 2017-09-30
T. Rowe Price Growth Stock 6373337 0.59% 249300 4.07% 2016-09-30
T. Rowe Price Capital Appreciation 4848159 0.45% -- -- 2016-12-31
T. Rowe Price Blue Chip Growth 4629626 0.43% -123000 -2.59% 2016-12-31
VA CollegeAmerica Amercn Bal 529E 3800000 0.35% -- -- 2016-12-31
SPDR® S&P 500 ETF 8489791 0.80% 63855 0.80% 2015-11-19
SPDR® S&P 500® ETF Trust 8075385 0.70% 8075385 -- 2015-09-30
Vanguard Dividend Appreciation Index 6228713 0.60% -12365 -0.20% 2015-10-31
VA CollegeAmerica Fundamental Investors 5375000 0.50% -- -- 2015-09-30
Kiwi Wealth KiwiSaver Growth 5287802 0.50% 5287802 -- 2015-03-31
T. Rowe Price Growth Stock Fund 4671000 0.40% -146800 -3.00% 2015-09-30
Fidelity Spartan® 500 Index Fd 4299314 0.40% 14845 0.40% 2015-09-30
Consumer Staples Select Sector SPDR® Fd 4098851 0.40% 7788 0.20% 2015-11-19
PowerShares QQQ 8757478 0.80% -69600 -0.80% 2015-11-19

Leonard D. Schaeffer Mr. Schaeffer is a Director of Amgen, Inc. and has been a Director of Allergan, Inc. since 1993. He is Chairman of Organization and Compensation Committee and is a Member of Corporate Governance Committee for Allergan, Inc. He is Chairman of National Institute for Health Care Management. He is a Member of Institute of Medicine. He was Chairman of WellPoint, Inc., Anthem, Inc., Blue Cross and Blue Shield of Georgia, Blue Cross and Blue Shield of Missouri, Blue Cross and Blue Shield of Wisconsin, Anthem Life Insurance Company, HealthLink and UniCare from November 2004 to November 2005. He was Chairman and Chief Executive Officer of WellPoint Health Networks, Inc. from 1992 to November 2004. He was Administrator of U.S. Health Care Financing Administration from 1978 to 1980.
David J. Brailer David J. Brailer founded Health Evolution Management Co. LLC. Presently, Dr. Brailer is Managing Partner & Chief Executive Officer at this company. He is also on the board of 7 other companies. In the past he occupied the position of Chairman for CenseoHealth LLC and Chairman & Chief Executive Officer of CareScience, Inc. Dr. Brailer received a doctorate and an undergraduate degree from West Virginia University and a doctorate from The Wharton School of the University of Pennsylvania.
Kathleen Wilson-Thompson Currently, Kathleen Wilson-Thompson is Global Chief Human Resources Officer & EVP at Walgreens Boots Alliance, Inc. She is also on the board of 7 other companies. In her past career she was Senior Vice President-Global Human Resources at Kellogg Co., Vice President & Staff Counsel at Michigan National Corp. and Chief Human Resources Officer & Senior VP at Walgreen Co. She received an undergraduate degree from the University of Michigan, a graduate degree from Wayne State University (Michigan) and a graduate degree from Wayne State University (Michigan).
James Kehoe Currently, James Kehoe is Global Chief Financial Officer & Executive VP at Walgreens Boots Alliance, Inc. In the past Mr. Kehoe was Director at Takeda Pharmaceutical Co., Ltd., EVP, Chief Financial & Administrative Officer at Gildan Activewear, Inc., Chief Financial Officer & Executive Vice President of Kraft Foods Group, Inc. and Chief Accounting Officer & Senior VP-Finance at Kraft Foods Group, Inc. James Kehoe received a graduate degree from University College Dublin and an undergraduate degree from National University of Ireland.
James A. Skinner Mr. James A. Skinner is a Lead Independent Director at Illinois Tool Works, Inc., an Executive Chairman at Walgreens Boots Alliance, Inc., a Non-Executive Chairman at Walgreen Co., a Member at The Chicago Club, a Member at The Chicago Council on Global Affairs, a Member at The Commercial Club of Chicago, a Member at The Economic Club of Chicago and a Member at The Executives Club of Chicago. He is on the Board of Directors at Illinois Tool Works, Inc. and The Museum of Science & Industry. Mr. Skinner was previously employed as an Independent Director by HP, Inc., a Vice Chairman & Chief Executive Officer by McDonald's Corp., a President & Chief Operating Officer by McDonald's Restaurant Operations, Inc., a President & Chief Operating Officer by McDonald's Europe Ltd., and a Trustee by Ronald McDonald House Charities, Inc. He also served on the board at Catalyst, Inc.
William C. Foote Mr. William C. Foote is a Lead Independent Director at Walgreens Boots Alliance, Inc., a Member at The Phi Beta Kappa Society and a Member-Civic Committee at The Business Roundtable. He is on the Board of Directors at Walgreens Boots Alliance, Inc., National Association of Manufacturers, Northwestern Memorial HealthCare and Williams College. Mr. Foote was previously employed as an Independent Director by Walgreen Co., a Chairman by USG Corp., a Chairman by Federal Reserve Bank of Chicago, a President & Chief Executive Officer by L&W Supply Corp., a Senior Manager-Engagement by McKinsey & Co., Inc., a Trustee by Northwestern Memorial Hospital, a Member-Civic Committee by The Century Club, an Assistant Treasurer by The Chase Manhattan Bank NA, a Trustee by The Museum of Science & Industry, and a President & Chief Executive Officer by USG Interiors LLC. He also served on the board at CGC, Inc. and Kohler Co. He received his undergraduate degree from Williams College and an MBA from Harvard Business School.
Ginger L. Graham Ginger L. Graham is a businessperson who has been at the head of 6 different companies. Presently, Ms. Graham occupies the position of Chairman for Clovis Oncology, Inc. She is also on the board of 6 other companies. In her past career Ms. Graham held the position of President & Chief Executive Officer of Two Trees Consulting, President & Vice President at Vascular Intervention, Principal at Eli Lilly & Co., Director at Proteus Digital Health, Inc., Chairman of Guidant Corp., President, Chief Executive Officer & Director at Amylin Pharmaceuticals, Inc., President & Chief Executive Officer at Abbott Cardiovascular Systems, Inc., Senior Lecturer at Harvard Business School and Chairman-Scientific Council at the University of Colorado at Denver. Ms. Graham received an undergraduate degree from The University of Arkansas and an MBA from Harvard Business School.
John Anthony Lederer Founder of President's Choice Children's Charity, John Anthony Lederer is a businessperson who has been at the helm of 6 different companies and is Executive Chairman for Staples, Inc. He is also on the board of 6 other companies. In the past Mr. Lederer held the position of Chairman of President's Choice Children's Charity, Chairman & Chief Executive Officer of Duane Reade, Inc., President, Chief Executive Officer & Director at US Foods, Inc. and President at Loblaw Cos. Ltd. John Anthony Lederer received an undergraduate degree from York University.
Marco Pagni Presently, Marco Pagni occupies the position of Global CAO, Executive VP & General Counsel at Walgreens Boots Alliance, Inc. He is also on the board of Boots Management Services Ltd., Alliance Boots Services GmbH and Boots IP GmbH. In his past career he occupied the position of European Counsel at Texas Instruments Incorporated, General Counsel for McDonald's Corp., Chief Administrative Officer & Group Legal Counsel at Alliance Boots GmbH, Member of Bar of England & Wales and Secretary & General Counsel of Alliance UniChem Plc. Mr. Pagni received an undergraduate degree from the University of Oxford.
Stefano Pessina Mr. Stefano Pessina is a Chief Executive Officer & Director at Walgreen Co., an Executive Vice Chairman & Chief Executive Officer at Walgreens Boots Alliance, Inc. and an Executive Chairman at Walgreens Boots Alliance Ltd. He is on the Board of Directors at Walgreen Co., Walgreens Boots Alliance, Inc., Sprint Acquisitions Holdings Ltd., The Consumer Goods Forum and Vifor Pharma Management AG. Mr. Pessina was previously employed as an Executive Chairman by Alliance Boots GmbH, an Executive Chairman by Alliance Boots Holdings Ltd., a Non-Executive Director by Vifor Pharma AG, and an Executive Deputy Chairman by Alliance UniChem Plc. He received his undergraduate degree from Politecnico di Milano.
Ornella Barra Founder of Dipharma Francis SRL and European Pharmacists Forum, Ornella Barra currently is Chairman of International Federation of Pharmaceutical Wholesalers. She is also on the board of AmerisourceBergen Corp., ADF Associazione Distributori Farmaceutici and Efficient Consumer Response Belgium and Co-Chief Operating Officer at Walgreens Boots Alliance, Inc. and Chief Executive Officer-Global Wholesale Division at Walgreen Co. She previously occupied the position of General Manager for Alleanza Salute Italia Spa, Director & Director-Wholesale & Commercial Affairs at Alliance Boots Holdings Ltd. and Director & CEO-Wholesale & Brands at Alliance Boots GmbH. Ms. Barra received an undergraduate degree from Genova State University.
Jos�0�1�0�8 E. Almeida Jos�0�1�0�8 E. Almeida is a businessperson who has been at the helm of 5 different companies and presently is Chairman, President & Chief Executive Officer for Baxter International, Inc. and President of Baxter Healthcare Corp. (a subsidiary of Baxter International, Inc.). Mr. Almeida is also Member of The Business Roundtable and on the board of 5 other companies. In the past Jos�0�1�0�8 E. Almeida occupied the position of Chief Operating Officer & Executive Vice President of Integer Holdings Corp., Engineering Manager-Professional Products Division at Johnson & Johnson, Manufacturing Director at Acufex Microsurgical, Inc., President-Worldwide Medical Device Business at Tyco Healthcare (Illinois), Chairman, President & Chief Executive Officer for Covidien Plc, President of Covidien LP, Senior Vice President & President-Medical Supplies at Covidien New Zealand Ltd. and Chairman for Advanced Medical Technology Association. Jos�0�1�0�8 E. Almeida received an undergraduate degree from Instituto Mau�0�1�0�3 de Tecnologia.
Gunjan Bhow Gunjan Bhow is Chief Digital Officer of Walgreens Boots Alliance, Inc. In his past career Mr. Bhow was Vice President-Strategy & GM-New Ventures at Plantronics, Inc. and Vice President-Sales & Marketing at Actiontec Electronics, Inc. He received an MBA from Harvard University and an undergraduate degree from the University of California, Berkeley.
Nancy M. Schlichting Nancy M. Schlichting is Director-Detroit Branch at Federal Reserve Bank of Chicago and on the board of 9 other companies. She previously occupied the position of President & Chief Executive Officer at Henry Ford Hospital, President & Chief Executive Officer of The Riverside Methodist Hospital, Chairman at Detroit Regional Chamber, Chief Executive Officer for Henry Ford Health System, Inc., Chief Operating Officer at Summa Health System, Inc., Chief Operating Officer for Summa Akron City Hospital and President-Eastern Region at Catholic Health Initiatives. She received an undergraduate degree from Duke University and an MBA from Cornell University.
Alexander W. Gourlay Mr. Alexander W. Gourlay is a Co-Chief Operating Officer at Walgreens Boots Alliance, Inc., a President at Walgreen Co., a Director at World Business Chicago and a Member at Royal Pharmaceutical Society of Great Britain. He is on the Board of Directors at Retail Industry Leaders Association. Mr. Gourlay was previously employed as a Trustee & Chairman-Environment Leadership Team by Business in the Community, a Director, CEO-Health & Beauty Division by Alliance Boots GmbH, a Chief Executive Officer by Alliance Boots Holdings Ltd., a Director-Healthcare & Store Development by Boots Group Plc, and a Chairman by National Association of Chain Drug Stores, Inc. He also served on the board at Walgreens Boots Alliance Ltd.
Marco Pagni Presently, Marco Pagni occupies the position of Global CAO, Executive VP & General Counsel at Walgreens Boots Alliance, Inc. He is also on the board of Boots Management Services Ltd., Alliance Boots Services GmbH and Boots IP GmbH. In his past career he occupied the position of European Counsel at Texas Instruments Incorporated, General Counsel for McDonald's Corp., Chief Administrative Officer & Group Legal Counsel at Alliance Boots GmbH, Member of Bar of England & Wales and Secretary & General Counsel of Alliance UniChem Plc. Mr. Pagni received an undergraduate degree from the University of Oxford.
Gerald Gradwell Currently, Gerald Gradwell is Investor Relations Contact at Walgreens Boots Alliance, Inc. In the past he was Director-Investor Relations for Alliance Boots GmbH and Director-Investor Relations at Alliance UniChem Plc.
Dominic Patrick Murphy Founder of 8C Capital LLP, Dominic Patrick Murphy is Chief Executive Officer at this company. He is also Member-Development Council at National Portrait Gallery (London) and on the board of 5 other companies. In the past he held the position of Investment Manager at 3i Group Plc, Partner at Cinven Ltd., Member of Kohlberg Kravis Roberts & Co. Ltd. and Member-Corporate Partnerships Board at Great Ormond Street Hospital Children's Charity. He received an undergraduate degree from The University of Liverpool.
Sebastian Richard Edward James Sebastian Richard Edward James is a businessperson who has been at the helm of 5 different companies. Presently, he is Chairman of INK Publishing (Holdings) Ltd. He is also Senior Vice President at Walgreens Boots Alliance, Inc. and on the board of 6 other companies. In his past career he occupied the position of Group Chief Executive Officer & Executive Director at Dixons Carphone Plc and Group Chief Executive Officer & Executive Director at Dixons Retail Group Ltd. (a subsidiary of Dixons Carphone Plc), Strategy Director at Mothercare Plc and Chief Executive Officer at Synergy Insurance Services (UK) Ltd. He received an MBA from INSEAD and a graduate degree from the University of Oxford.
Janice M. Babiak Ms. Janice M. Babiak is an Independent Non-Executive Director at Euromoney Institutional Investor Plc, an Independent Director at Bank of Montreal, an Independent Director at Walgreens Boots Alliance, Inc., a Council Member at Institute of Chartered Accountants in England & Wales and a Partner at HHM Plus LLC. She is on the Board of Directors at Euromoney Institutional Investor Plc, Bank of Montreal, Walgreen Co., Walgreens Boots Alliance, Inc., GlobalLogic, Inc. and GHD Group Pty Ltd. Ms. Babiak was previously employed as an Independent Non-Executive Director by Experian Plc, an Independent Non-Executive Director by Royal Mail Plc, a Non-Executive Director by Royal Mail Group Ltd., an Independent Non-Executive Director by Logica Plc, and a Managing Partner by Ernst & Young LLP /UK/. She received her undergraduate degree from the University of Oklahoma and an MBA from Baldwin-Wallace College.
Alexander W. Gourlay Mr. Alexander W. Gourlay is a Co-Chief Operating Officer at Walgreens Boots Alliance, Inc., a President at Walgreen Co., a Director at World Business Chicago and a Member at Royal Pharmaceutical Society of Great Britain. He is on the Board of Directors at Retail Industry Leaders Association. Mr. Gourlay was previously employed as a Trustee & Chairman-Environment Leadership Team by Business in the Community, a Director, CEO-Health & Beauty Division by Alliance Boots GmbH, a Chief Executive Officer by Alliance Boots Holdings Ltd., a Director-Healthcare & Store Development by Boots Group Plc, and a Chairman by National Association of Chain Drug Stores, Inc. He also served on the board at Walgreens Boots Alliance Ltd.
Leonard D. Schaeffer Mr. Schaeffer is a Director of Amgen, Inc. and has been a Director of Allergan, Inc. since 1993. He is Chairman of Organization and Compensation Committee and is a Member of Corporate Governance Committee for Allergan, Inc. He is Chairman of National Institute for Health Care Management. He is a Member of Institute of Medicine. He was Chairman of WellPoint, Inc., Anthem, Inc., Blue Cross and Blue Shield of Georgia, Blue Cross and Blue Shield of Missouri, Blue Cross and Blue Shield of Wisconsin, Anthem Life Insurance Company, HealthLink and UniCare from November 2004 to November 2005. He was Chairman and Chief Executive Officer of WellPoint Health Networks, Inc. from 1992 to November 2004. He was Administrator of U.S. Health Care Financing Administration from 1978 to 1980.
Ken Murphy Ken Murphy is on the board of The Boots Co. Plc, Boots International Ltd. and Soap & Glory Ltd. and Executive Vice President at Walgreens Boots Alliance, Inc.
Annie Louise Murphy Annie Louise Murphy is on the board of Nomad Foods Europe Ipco Ltd. and Chief Commercial Officer of Walgreens Boots Alliance, Inc. In the past she held the position of Commercial Director at Boots UK Ltd.
Leonard D. Schaeffer Mr. Schaeffer is a Director of Amgen, Inc. and has been a Director of Allergan, Inc. since 1993. He is Chairman of Organization and Compensation Committee and is a Member of Corporate Governance Committee for Allergan, Inc. He is Chairman of National Institute for Health Care Management. He is a Member of Institute of Medicine. He was Chairman of WellPoint, Inc., Anthem, Inc., Blue Cross and Blue Shield of Georgia, Blue Cross and Blue Shield of Missouri, Blue Cross and Blue Shield of Wisconsin, Anthem Life Insurance Company, HealthLink and UniCare from November 2004 to November 2005. He was Chairman and Chief Executive Officer of WellPoint Health Networks, Inc. from 1992 to November 2004. He was Administrator of U.S. Health Care Financing Administration from 1978 to 1980.
Richard M. Ashworth Mr. Richard M. Ashworth is a President-Operations at Walgreen Co., a VP-Pharmacy Benefit Management Services at Walgreens Health Services, Inc. and a President-Operations at Walgreens Boots Alliance, Inc. He is on the Board of Directors at National Association of Chain Drug Stores, Inc. Mr. Ashworth was previously employed as a Director-Healthcare, Health & Beauty by Alliance Boots GmbH and an Executive VP-Pharmacy Benefit Management Services by Catamaran PBM of Illinois II, Inc. He received his MBA from the University of Phoenix and a doctorate degree from Nova Southeastern University, Inc..
Anas Al-Hamwi Anas Al-Hamwi is on the board of National Safety Council and Senior Director-Safety & Injury Management at Walgreens Boots Alliance, Inc.
Heather Dixon Heather Dixon is former Chief Accounting Officer, VP & Controller for Aetna, Inc.
Richard M. Ashworth Mr. Richard M. Ashworth is a President-Operations at Walgreen Co., a VP-Pharmacy Benefit Management Services at Walgreens Health Services, Inc. and a President-Operations at Walgreens Boots Alliance, Inc. He is on the Board of Directors at National Association of Chain Drug Stores, Inc. Mr. Ashworth was previously employed as a Director-Healthcare, Health & Beauty by Alliance Boots GmbH and an Executive VP-Pharmacy Benefit Management Services by Catamaran PBM of Illinois II, Inc. He received his MBA from the University of Phoenix and a doctorate degree from Nova Southeastern University, Inc..
Joseph B. Amsbary Presently, Joseph B. Amsbary holds the position of Secretary & Vice President at Walgreens Boots Alliance, Inc.
Vineet Mehra Vineet Mehra holds the position of Chief Marketing Officer of Walgreens Boots Alliance, Inc.
Colin Nelson Colin Nelson is Chief Supply Chain Officer at Walgreens Boots Alliance, Inc.

量化对比

全部评论 3

  • Walgreens Boots Alliance(WBA)和VillageMD已经达成协议,将在未来5年来在500到700家药店内开始医生诊所。

  • 道指成分股中,卡特彼勒转涨拉升3.26%,Walgreens Boots Alliance涨3.28%,宝洁与强生微涨。

  • 美国连锁药店Walgreens Boots Alliance涨超6%,KKR跌0.9%;此前有报道称,私募股权公司KKR正在与Walgreens接洽,准备收购后者,这可能是有史以来规模最大的杠杆收购交易。

阿布量化公众号二维码 abu_quant 扫一扫关注阿布量化

热门推荐